Burtness B - Search Results

1

Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer.

Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Burtness B, et al. Ann Oncol. 2009 Jul;20(7):1242-8. doi: 10.1093/annonc/mdn787. Epub 2009 May 8. Ann Oncol. 2009. PMID: 19429872 Free PMC article. Clinical Trial.

2

Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer.

Murren JR, Anderson S, Fedele J, Pizzorno G, Belliveau D, Zelterman D, Burtness BA, Tocino I, Flynn SD, Beidler D, Cheng YC. Murren JR, et al. Among authors: burtness ba. J Clin Oncol. 1997 Jan;15(1):148-57. doi: 10.1200/JCO.1997.15.1.148. J Clin Oncol. 1997. PMID: 8996136

3

Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.

Heath EI, Burtness BA, Heitmiller RF, Salem R, Kleinberg L, Knisely JP, Yang SC, Talamini MA, Kaufman HS, Canto MI, Topazian M, Wu TT, Olukayode K, Forastiere AA. Heath EI, et al. Among authors: burtness ba. J Clin Oncol. 2000 Feb;18(4):868-76. doi: 10.1200/JCO.2000.18.4.868. J Clin Oncol. 2000. PMID: 10673530 Clinical Trial.

4

Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer.

Murren JR, Peccerillo K, DiStasio SA, Li X, Leffert JJ, Pizzorno G, Burtness BA, McKeon A, Cheng Y. Murren JR, et al. Among authors: burtness ba. Cancer Chemother Pharmacol. 2000;46(1):43-50. doi: 10.1007/s002800000115. Cancer Chemother Pharmacol. 2000. PMID: 10912577 Clinical Trial.

5

Phase I study of perillyl alcohol in patients with refractory malignancies.

Murren JR, Pizzorno G, DiStasio SA, McKeon A, Peccerillo K, Gollerkari A, McMurray W, Burtness BA, Rutherford T, Li X, Ho PT, Sartorelli A. Murren JR, et al. Cancer Biol Ther. 2002 Mar-Apr;1(2):130-5. doi: 10.4161/cbt.57. Cancer Biol Ther. 2002. PMID: 12170772 Free article. Clinical Trial.

6

Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer.

Bleickardt E, Argiris A, Rich R, Blum K, McKeon A, Tara H, Zelterman D, Burtness B, Davies MJ, Murren JR. Bleickardt E, et al. Among authors: burtness b. Cancer Biol Ther. 2002 Nov-Dec;1(6):646-51. doi: 10.4161/cbt.314. Cancer Biol Ther. 2002. PMID: 12642688 Free article. Review.

7

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA. Kleinberg L, et al. Among authors: burtness b. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34. doi: 10.1016/s0360-3016(02)04598-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738305 Clinical Trial.

8

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.

Gibson MK, Abraham SC, Wu TT, Burtness B, Heitmiller RF, Heath E, Forastiere A. Gibson MK, et al. Among authors: burtness b. Clin Cancer Res. 2003 Dec 15;9(17):6461-8. Clin Cancer Res. 2003. PMID: 14695149

9

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL. Psyrri A, et al. Among authors: burtness ba. J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108. J Clin Oncol. 2004. PMID: 15284256 Clinical Trial.

10

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.

Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA; Eastern Cooperative Oncology Group. Burtness B, et al. J Clin Oncol. 2005 Dec 1;23(34):8646-54. doi: 10.1200/JCO.2005.02.4646. J Clin Oncol. 2005. PMID: 16314626 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters